KEVIN D. FREEMAN - 28 Oct 2022 Form 4 Insider Report for GALECTIN THERAPEUTICS INC (GALT)

Role
Director
Signature
Jack W. Callicutt, by power of attorney
Issuer symbol
GALT
Transactions as of
28 Oct 2022
Transactions value $
$14,100
Form type
4
Filing time
31 Oct 2022, 09:47:17 UTC
Previous filing
20 May 2022
Next filing
30 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GALT Common Stock Purchase $14,100 +10,000 +15% $1.41 75,000 28 Oct 2022 By a limited liability company controlled by the Reporting Person: Freeman Global Holdings LLC F1
holding GALT Common Stock 23,469 28 Oct 2022 Direct
holding GALT Common Stock 16,000 28 Oct 2022 IRA
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.